116 related articles for article (PubMed ID: 8861048)
1. Consequences of current patterns of Pap smear and colposcopy use.
Kavanagh AM; Santow G; Mitchell H
J Med Screen; 1996; 3(1):29-34. PubMed ID: 8861048
[TBL] [Abstract][Full Text] [Related]
2. The burden of prevention: downstream consequences of Pap smear testing in the elderly.
Sirovich BE; Gottlieb DJ; Fisher ES
J Med Screen; 2003; 10(4):189-95. PubMed ID: 14738656
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology.
Budge M; Halford J; Haran M; Mein J; Wright G
Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):215-9. PubMed ID: 15904447
[TBL] [Abstract][Full Text] [Related]
4. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
5. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence?
Melnikow J; Chan BK; Stewart GK
Arch Fam Med; 1999; 8(6):510-4. PubMed ID: 10575390
[TBL] [Abstract][Full Text] [Related]
6. Sociodemographic factors associated with cervical cancer screening coverage and follow-up of high grade abnormal results in a population-based cohort.
Elit L; Saskin R; Raut R; Elliott L; Murphy J; Marrett L
Gynecol Oncol; 2013 Jan; 128(1):95-100. PubMed ID: 23085459
[TBL] [Abstract][Full Text] [Related]
7. The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan.
Chang JI; Ou CH; Wu KM; Chen CC; Cheng KC
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):430-4. PubMed ID: 12433029
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening among women without a cervix.
Sirovich BE; Welch HG
JAMA; 2004 Jun; 291(24):2990-3. PubMed ID: 15213211
[TBL] [Abstract][Full Text] [Related]
9. Risk of cervical cancer after a negative Pap smear.
Viikki M; Pukkala E; Hakama M
J Med Screen; 1999; 6(2):103-7. PubMed ID: 10444730
[TBL] [Abstract][Full Text] [Related]
10. Predicting nonattendance for colposcopy clinic follow-up after referral for an abnormal Pap smear.
Kavanagh AM; Simpson JM
Aust N Z J Public Health; 1996 Jun; 20(3):266-71. PubMed ID: 8768416
[TBL] [Abstract][Full Text] [Related]
11. Use of and attitudes and knowledge about pap smears among women in Kuwait.
El-Hammasi K; Samir O; Kettaneh S; Al-Fadli A; Thalib L
J Womens Health (Larchmt); 2009 Nov; 18(11):1825-32. PubMed ID: 19951218
[TBL] [Abstract][Full Text] [Related]
12. Impact of Patient-Directed Cytology Results Correspondence Program on Follow-Up of High-Grade Pap Tests.
Tavasoli SM; Kane E; Kupets R
J Obstet Gynaecol Can; 2019 Oct; 41(10):1461-1469. PubMed ID: 31053566
[TBL] [Abstract][Full Text] [Related]
13. Predictors of adherence to follow-up recommendations after an abnormal Pap smear among underserved inner-city women.
Miller SM; Tagai EK; Wen KY; Lee M; Hui SA; Kurtz D; Scarpato J; Hernandez E
Patient Educ Couns; 2017 Jul; 100(7):1353-1359. PubMed ID: 28190541
[TBL] [Abstract][Full Text] [Related]
14. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
Soccio J; Brown M; Comino E; Friesen E
J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
[TBL] [Abstract][Full Text] [Related]
15. Abnormal Pap smear follow-up in a high-risk population.
Engelstad LP; Stewart SL; Nguyen BH; Bedeian KL; Rubin MM; Pasick RJ; Hiatt RA
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1015-20. PubMed ID: 11588126
[TBL] [Abstract][Full Text] [Related]
16. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?
Perkins RB; Langrish SM; Stern LJ; Figueroa J; Simon CJ
Trop Med Int Health; 2007 Sep; 12(9):1018-25. PubMed ID: 17875013
[TBL] [Abstract][Full Text] [Related]
17. Impact of media reporting of cervical cancer in a UK celebrity on a population-based cervical screening programme.
MacArthur GJ; Wright M; Beer H; Paranjothy S
J Med Screen; 2011; 18(4):204-9. PubMed ID: 22156146
[TBL] [Abstract][Full Text] [Related]
18. Cervical cancer screening in Western Australia in 1992: progress since 1983.
Straton JA; Holman CD; Edwards BM
Med J Aust; 1993 Nov; 159(10):657-61. PubMed ID: 8232008
[TBL] [Abstract][Full Text] [Related]
19. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
20. No increased risk for cervical cancer after a broader definition of a negative Pap smear.
Rebolj M; van Ballegooijen M; van Kemenade F; Looman C; Boer R; Habbema JD
Int J Cancer; 2008 Dec; 123(11):2632-5. PubMed ID: 18767046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
